Four paths are currently pursued:
Role of economic analysis in decision-making (RE1)
Analyzing the role of economics in decision-making is a natural first step for the study of regulation in the health care field.
- “Benchmark study” (RE11)
- “Linking value of statistical life (VSL) and QALYs” (RE12)
Optimal payment schemes (RE2)
The activity-based payment scheme (Tarification à l’Activité – T2A) and the payment for performance initiatives are central and raise many questions. What are the effects on quality ? on cooperation between teams ? for public hospitals as regards the the coming health Law ?
The objective under this section is to encourage research on these topics.
- “Hospital performance measurement” (RE21)
- “Hospital competition, collaboration and merging” (RE22)
- “Incentivizing ambulatory care” (RE23)
- “Access to Accident and Emergency services” (RE24)
Optimal pricing for innovation (RE3)
Hospinnomics analyses the formation of prices, notably drug pricing.
- “Drug pricing” (RE31)
- “Rare cancers & Orphan Drugs: innovation & inequality” (RE32)
Inequalities in demand and access to care (RE4)
Inequalities in demand and access to care require both adequate measurements and methods to ensure they are taken into account in the evaluations carried out in health care. Other issues are central, such as the importance of income or education differences in access to health care services or in investments in prevention.
Hospinnomics’ objective is to contribute to this active research area, with a multidisciplinary approach.
- “Out-of-pocket payments in hospitals” (RE41)
- “Migrant population access to hospital care” (RE42)
- “Rare diseases and inequalities” (RE43)